María Garcés‐Sánchez

1.2k total citations
66 papers, 756 citations indexed

About

María Garcés‐Sánchez is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, María Garcés‐Sánchez has authored 66 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 21 papers in Infectious Diseases and 20 papers in Health. Recurrent topics in María Garcés‐Sánchez's work include Respiratory viral infections research (35 papers), Pneumonia and Respiratory Infections (27 papers) and Vaccine Coverage and Hesitancy (20 papers). María Garcés‐Sánchez is often cited by papers focused on Respiratory viral infections research (35 papers), Pneumonia and Respiratory Infections (27 papers) and Vaccine Coverage and Hesitancy (20 papers). María Garcés‐Sánchez collaborates with scholars based in Spain, Belgium and United Kingdom. María Garcés‐Sánchez's co-authors include Federico Martinón‐Torres, Javier Díez‐Domingo, Fabiola Martin, J.J. Picazo, Ignacio Salamanca de la Cueva, F. Giménez Sánchez, Beatriz Ramos, Francisco José Álvarez García, Helen Marshall and Leszek Szenborn and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and The Lancet Infectious Diseases.

In The Last Decade

María Garcés‐Sánchez

56 papers receiving 724 citations

Peers

María Garcés‐Sánchez
Sarah S. Long United States
Stephanie Jones South Africa
Rafik Bekkat-Berkani United States
B. Ultsch Germany
Victor K. Wong United States
Larry Pickering United States
María Garcés‐Sánchez
Citations per year, relative to María Garcés‐Sánchez María Garcés‐Sánchez (= 1×) peers David Moreno‐Pérez

Countries citing papers authored by María Garcés‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of María Garcés‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Garcés‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Garcés‐Sánchez more than expected).

Fields of papers citing papers by María Garcés‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Garcés‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Garcés‐Sánchez. The network helps show where María Garcés‐Sánchez may publish in the future.

Co-authorship network of co-authors of María Garcés‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of María Garcés‐Sánchez. A scholar is included among the top collaborators of María Garcés‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Garcés‐Sánchez. María Garcés‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wildenbeest, Joanne, Roderick P Venekamp, Beatrice Casini, et al.. (2025). Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021–23). The Lancet Respiratory Medicine. 13(2). 153–165. 9 indexed citations
2.
García, Francisco José Álvarez, María Garcés‐Sánchez, Abián Montesdeoca Melián, et al.. (2024). Immunisation schedule of the Spanish Association of Pediatrics: 2024 recommendations. SHILAP Revista de lepidopterología. 100(1). 34–45. 1 indexed citations
3.
López‐Lacort, Mónica, Cintia Muñoz-Quiles, Ainara Mira‐Iglesias, et al.. (2024). Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting. PEDIATRICS. 155(1). 17 indexed citations
5.
Mestre-Ferrándiz, Jorge, Alejandro Orrico‐Sánchez, Javier Álvarez, et al.. (2024). Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain. BMC Infectious Diseases. 24(1). 99–99.
6.
Llop, F.A. Moraga, María Garcés‐Sánchez, & Juan José González‐López. (2024). Reemergence of pertussis: Strategies and challenges in its control in Spain. SHILAP Revista de lepidopterología. 101(4). 227–229. 1 indexed citations
7.
Cueva, Ignacio Salamanca de la, et al.. (2023). Historical review of vaccination against meningococcus in Spain (1996–2021). Learned lessons. 24(1). 45–54. 1 indexed citations
8.
García, Francisco José Álvarez, María José Cilleruelo Ortega, María Garcés‐Sánchez, et al.. (2023). Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations. SHILAP Revista de lepidopterología. 98(1). 58.e1–58.e10. 8 indexed citations
9.
Garcés‐Sánchez, María, et al.. (2023). The impact of the pandemic on vaccination coverage in Spain: A challenge for pediatrics and public health. SHILAP Revista de lepidopterología. 100(1). 1–2. 2 indexed citations
10.
Orrico‐Sánchez, Alejandro, et al.. (2023). Efficacy and effectiveness of influenza vaccination in healthy children. A review of current evidence. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(7). 396–406. 4 indexed citations
11.
Garcés‐Sánchez, María, et al.. (2021). Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season. BMC Medical Research Methodology. 21(1). 273–273. 2 indexed citations
12.
Garcés‐Sánchez, María, et al.. (2020). HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public health reviews. 41(1). 10–10. 79 indexed citations
13.
Díez‐Domingo, Javier, et al.. (2019). ¿Qué hemos aprendido sobre rotavirus en España en los últimos 10 años?. Anales de Pediatría. 91(3). 166–179. 19 indexed citations
14.
Garcés‐Sánchez, María, et al.. (2015). Vacuna triple vírica. Resurgimiento del sarampión en Europa. Enfermedades Infecciosas y Microbiología Clínica. 33(10). 673–678. 5 indexed citations
15.
Richmond, Peter, Helen Marshall, Michael D. Nissen, et al.. (2012). Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 12(8). 597–607. 108 indexed citations
16.
Garcés‐Sánchez, María, et al.. (2011). Diagnóstico, tratamiento y prevención de la otitis media aguda en la infancia. Acta pediátrica española. 69(4). 151–155.
17.
Ballester, Alfredo, et al.. (2008). Pediatric Safety Evaluation of An AS-Adjuvanted H5N1 Prepandemic Candidate Vaccine in Children Aged 3–9 Years: A Phase II Study. International Journal of Infectious Diseases. 12. e146–e146. 7 indexed citations
18.
Martinón‐Torres, Federico, et al.. (2008). ¿Por qué hay más empiemas pediátricos en España?. Anales de Pediatría. 68(2). 158–164. 13 indexed citations
19.
Garcés‐Sánchez, María. (2006). Calendario vacunal 2006 de la asociación española de pediatría. 7–10.
20.
Sánchez, F. Giménez, et al.. (2006). El papel de la vacuna frente a rotavirus en los calendarios de vacunación infantil. Anales de Pediatría. 64(6). 573–577. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026